Ciapetti M, et al. – Here, the clinicians intended to inquire the variations of non–enzymatic antioxidants in plasma during veno–venous ECMO–treatment in a homogeneous population of critical patients with ARDS. It was shown that the veno–venous ECMO–treatment causes a significant reduction of some of the major non–enzymatic antioxidants and a possible increase in insulin resistance in patients with ARDS by influence A H1N1.